Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP276778.RARHppYad9-SBYTOE5ntZ1dVeS1VcEOMV60-c4LATe60U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP276778.RARHppYad9-SBYTOE5ntZ1dVeS1VcEOMV60-c4LATe60U130_assertion type Assertion NP276778.RARHppYad9-SBYTOE5ntZ1dVeS1VcEOMV60-c4LATe60U130_head.
- NP276778.RARHppYad9-SBYTOE5ntZ1dVeS1VcEOMV60-c4LATe60U130_assertion description "[This study was intended to evaluate the prognostic and diagnostic significance of carbonic anhydrase IX (CA IX) and soluble urokinase plasminogen activator receptor (suPAR) levels in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276778.RARHppYad9-SBYTOE5ntZ1dVeS1VcEOMV60-c4LATe60U130_provenance.
- NP276778.RARHppYad9-SBYTOE5ntZ1dVeS1VcEOMV60-c4LATe60U130_assertion evidence source_evidence_literature NP276778.RARHppYad9-SBYTOE5ntZ1dVeS1VcEOMV60-c4LATe60U130_provenance.
- NP276778.RARHppYad9-SBYTOE5ntZ1dVeS1VcEOMV60-c4LATe60U130_assertion SIO_000772 23512428 NP276778.RARHppYad9-SBYTOE5ntZ1dVeS1VcEOMV60-c4LATe60U130_provenance.
- NP276778.RARHppYad9-SBYTOE5ntZ1dVeS1VcEOMV60-c4LATe60U130_assertion wasDerivedFrom befree-20150227 NP276778.RARHppYad9-SBYTOE5ntZ1dVeS1VcEOMV60-c4LATe60U130_provenance.
- NP276778.RARHppYad9-SBYTOE5ntZ1dVeS1VcEOMV60-c4LATe60U130_assertion wasGeneratedBy ECO_0000203 NP276778.RARHppYad9-SBYTOE5ntZ1dVeS1VcEOMV60-c4LATe60U130_provenance.